BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fattahi S, Amjadi-Moheb F, Tabaripour R, Ashrafi GH, Akhavan-Niaki H. PI3K/AKT/mTOR signaling in gastric cancer: Epigenetics and beyond. Life Sci 2020;262:118513. [PMID: 33011222 DOI: 10.1016/j.lfs.2020.118513] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 8.5] [Reference Citation Analysis]
Number Citing Articles
1 Najar MA, Arefian M, Sidransky D, Gowda H, Prasad TSK, Modi PK, Chatterjee A. Tyrosine Phosphorylation Profiling Revealed the Signaling Network Characteristics of CAMKK2 in Gastric Adenocarcinoma. Front Genet 2022;13:854764. [DOI: 10.3389/fgene.2022.854764] [Reference Citation Analysis]
2 Liu X, Wang S, Li J, Zhang J, Liu D. Regulatory effect of traditional Chinese medicines on signaling pathways of process from chronic atrophic gastritis to gastric cancer. Chinese Herbal Medicines 2021. [DOI: 10.1016/j.chmed.2021.10.008] [Reference Citation Analysis]
3 Li T, Zhang X, Cheng L, Li C, Wu Z, Luo Y, Zhou K, Li Y, Zhao Q, Huang Y. Modulation of lncRNA H19 enhances resveratrol-inhibited cancer cell proliferation and migration by regulating endoplasmic reticulum stress. J Cell Mol Med 2022. [PMID: 35166018 DOI: 10.1111/jcmm.17242] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Liu C, Hao, Ai M, Zhang Y, Li J, Xu C. The long non-coding RNA UPAT promotes gastric cancer cell progression via UHRF1. Genes Genomics 2022. [PMID: 35294719 DOI: 10.1007/s13258-022-01235-y] [Reference Citation Analysis]
5 Zhang W, Zhou L, Qin S, Jiang J, Huang Z, Zhang Z, Zhang X, Shi Z, Lin J. Sertaconazole provokes proapoptotic autophagy via stabilizing TRADD in nonsmall cell lung cancer cells. MedComm (2020) 2021;2:821-37. [PMID: 34977879 DOI: 10.1002/mco2.102] [Reference Citation Analysis]
6 Zeng Z, Lan T, Wei Y, Wei X. CCL5/CCR5 axis in human diseases and related treatments. Genes Dis 2021. [PMID: 34514075 DOI: 10.1016/j.gendis.2021.08.004] [Reference Citation Analysis]
7 Yue Y, Lin X, Qiu X, Yang L, Wang R. The Molecular Roles and Clinical Implications of Non-Coding RNAs in Gastric Cancer. Front Cell Dev Biol 2021;9:802745. [PMID: 34966746 DOI: 10.3389/fcell.2021.802745] [Reference Citation Analysis]
8 He J, Han J, Liu J, Yang R, Wang J, Wang X, Chen X. Genetic and Epigenetic Impact of Chronic Inflammation on Colon Mucosa Cells. Front Genet 2021;12:722835. [PMID: 34764977 DOI: 10.3389/fgene.2021.722835] [Reference Citation Analysis]
9 Farahani DB, Akrami H, Moradi B, Mehdizadeh K, Fattahi MR. The Effect of hsa-miR-451b Knockdown on Biological Functions of Gastric Cancer Stem-Like Cells. Biochem Genet 2021. [PMID: 33725258 DOI: 10.1007/s10528-021-10057-8] [Reference Citation Analysis]
10 Wen S, Li C, Zhan X. Muti-omics integration analysis revealed molecular network alterations in human nonfunctional pituitary neuroendocrine tumors in the framework of 3P medicine. EPMA Journal. [DOI: 10.1007/s13167-022-00274-5] [Reference Citation Analysis]
11 Koh V, Chakrabarti J, Torvund M, Steele N, Hawkins JA, Ito Y, Wang J, Helmrath MA, Merchant JL, Ahmed SA, Shabbir A, Yan So JB, Yong WP, Zavros Y. Hedgehog transcriptional effector GLI mediates mTOR-Induced PD-L1 expression in gastric cancer organoids. Cancer Lett 2021;518:59-71. [PMID: 34126195 DOI: 10.1016/j.canlet.2021.06.007] [Reference Citation Analysis]
12 Liu Z, Li L, Li X, Hua M, Sun H, Zhang S. Prediction and prognostic significance of ALOX12B and PACSIN1 expression in gastric cancer by genome-wide RNA expression and methylation analysis. J Gastrointest Oncol 2021;12:2082-92. [PMID: 34790376 DOI: 10.21037/jgo-21-508] [Reference Citation Analysis]
13 Ma Y, Yang X, Han H, Wen Z, Yang M, Zhang Y, Fu J, Wang X, Yin T, Lu G, Qi J, Lin H, Wang X, Yang Y. Design, synthesis and biological evaluation of anilide (dicarboxylic acid) shikonin esters as antitumor agents through targeting PI3K/Akt/mTOR signaling pathway. Bioorg Chem 2021;111:104872. [PMID: 33838560 DOI: 10.1016/j.bioorg.2021.104872] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Zhao N, Zhang J, Zhao Q, Chen C, Wang H. Mechanisms of Long Non-Coding RNAs in Biological Characteristics and Aerobic Glycolysis of Glioma. Int J Mol Sci 2021;22:11197. [PMID: 34681857 DOI: 10.3390/ijms222011197] [Reference Citation Analysis]
15 Xu L, Chen X, Jiang H, Xu J, Wang L, Sun Y. NDUFC1 Is Upregulated in Gastric Cancer and Regulates Cell Proliferation, Apoptosis, Cycle and Migration. Front Oncol 2021;11:709044. [PMID: 34966665 DOI: 10.3389/fonc.2021.709044] [Reference Citation Analysis]
16 Pandey P, Khan F, Qari HA, Oves M. Rutin (Bioflavonoid) as Cell Signaling Pathway Modulator: Prospects in Treatment and Chemoprevention. Pharmaceuticals (Basel) 2021;14:1069. [PMID: 34832851 DOI: 10.3390/ph14111069] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
17 Li X, Liu C, Zhu Y, Rao H, Liu M, Gui L, Feng W, Tang H, Xu J, Gao WQ, Li L. SETD2 epidermal deficiency promotes cutaneous wound healing via activation of AKT/mTOR Signalling. Cell Prolif 2021;54:e13045. [PMID: 33949020 DOI: 10.1111/cpr.13045] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
18 Parate S, Kumar V, Lee G, Rampogu S, Hong JC, Lee KW. Marine-Derived Natural Products as ATP-Competitive mTOR Kinase Inhibitors for Cancer Therapeutics. Pharmaceuticals (Basel) 2021;14:282. [PMID: 33801030 DOI: 10.3390/ph14030282] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
19 Xu G, Fan L, Zhao S, OuYang C. MT1G inhibits the growth and epithelial-mesenchymal transition of gastric cancer cells by regulating the PI3K/AKT signaling pathway. Genet Mol Biol 2022;45:e20210067. [PMID: 35167648 DOI: 10.1590/1678-4685-GMB-2021-0067] [Reference Citation Analysis]
20 Wang J, Xu X, Wang T, Guo Q, Dai X, Guo H, Zhang W, Cheng S, Chen X, Ding L. Ceritinib increases sensitivity of AKT inhibitors to gastric cancer. Eur J Pharmacol 2021;896:173879. [PMID: 33515539 DOI: 10.1016/j.ejphar.2021.173879] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Fu K, Zhou H, Wang C, Gong L, Ma C, Zhang Y, Li Y. A review: Pharmacology and pharmacokinetics of Schisandrin A. Phytotherapy Research. [DOI: 10.1002/ptr.7456] [Reference Citation Analysis]
22 Wang Y, Fang Y, Zhao F, Gu J, Lv X, Xu R, Zhang B, Fang Z, Li Y. Identification of GGT5 as a Novel Prognostic Biomarker for Gastric Cancer and its Correlation With Immune Cell Infiltration. Front Genet 2022;13:810292. [DOI: 10.3389/fgene.2022.810292] [Reference Citation Analysis]
23 Mirzaei S, Hushmandi K, Zabolian A, Saleki H, Torabi SMR, Ranjbar A, SeyedSaleh S, Sharifzadeh SO, Khan H, Ashrafizadeh M, Zarrabi A, Ahn KS. Elucidating Role of Reactive Oxygen Species (ROS) in Cisplatin Chemotherapy: A Focus on Molecular Pathways and Possible Therapeutic Strategies. Molecules 2021;26:2382. [PMID: 33921908 DOI: 10.3390/molecules26082382] [Cited by in F6Publishing: 10] [Reference Citation Analysis]
24 Chen H, Hu X, Lan Y, Chen S, Xiang X, Tan Y, Zeng G, Guo Z, Li K, Zhang J. Puerarin promotes apoptosis and senescence of bladder cancer cells. Journal of Functional Foods 2022;91:105032. [DOI: 10.1016/j.jff.2022.105032] [Reference Citation Analysis]
25 Zhuang SH, Meng CC, Fu JJ, Huang J. Long non-coding RNA ELFN1-AS1-mediated ZBTB16 inhibition augments the progression of gastric cancer by activating the PI3K/AKT axis. Kaohsiung J Med Sci 2022. [PMID: 35451560 DOI: 10.1002/kjm2.12548] [Reference Citation Analysis]
26 Yao Q, Ke H, Yang Q, Liao G, Liu P, Wang F. Study on the Mechanism of MicroRNA551b-5p in Severe Acute Pancreatitis Capillary Leakage Syndrome. Disease Markers 2022;2022:1-6. [DOI: 10.1155/2022/6373757] [Reference Citation Analysis]
27 Li X, Zhou Y, Wen P, Yuan Y, Xiao Z, Shi H, Zhou H. Tumor suppressor LHX6 upregulation contributes to the inhibitory effect of miR-346 knockdown on colorectal cancer cell growth. Environ Toxicol 2021. [PMID: 34773443 DOI: 10.1002/tox.23410] [Reference Citation Analysis]
28 Zhou D, He Y, Li H, Huang W. KLK6 mediates stemness and metabolism of gastric carcinoma cells via the PI3K/AKT/mTOR signaling pathway. Oncol Lett 2021;22:824. [PMID: 34691251 DOI: 10.3892/ol.2021.13085] [Reference Citation Analysis]
29 Li Z, Liu B, Li C, Sun S, Zhang H, Sun S, Wang Z, Zhang X. NRBP2 Functions as a Tumor Suppressor and Inhibits Epithelial-to-Mesenchymal Transition in Breast Cancer. Front Oncol 2021;11:634026. [PMID: 33816275 DOI: 10.3389/fonc.2021.634026] [Reference Citation Analysis]
30 Qin H, Li X, Zhang W, Ding Z. LncRNA OGFRP1 promotes cell proliferation and suppresses cell radiosensitivity in gastric cancer by targeting the miR-149-5p/MAP3K3 axis. J Mol Histol. [DOI: 10.1007/s10735-022-10058-w] [Reference Citation Analysis]
31 Zhu L, Huang Y, Li H, Shao S. Helicobacter pylori promotes gastric cancer progression through the tumor microenvironment. Appl Microbiol Biotechnol 2022. [PMID: 35723694 DOI: 10.1007/s00253-022-12011-z] [Reference Citation Analysis]
32 Da W, Tao L, Zhu Y. The inhibitory effect of CTAB on human osteosarcoma through the PI3K/AKT signaling pathway. Int J Oncol 2021;59:42. [PMID: 34013357 DOI: 10.3892/ijo.2021.5222] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
33 Kisby GE, Spencer PS. Genotoxic Damage During Brain Development Presages Prototypical Neurodegenerative Disease. Front Neurosci 2021;15:752153. [PMID: 34924930 DOI: 10.3389/fnins.2021.752153] [Reference Citation Analysis]
34 Lin LL, Yang F, Zhang DH, Hu C, Yang S, Chen XQ. ARHGAP10 inhibits the epithelial-mesenchymal transition of non-small cell lung cancer by inactivating PI3K/Akt/GSK3β signaling pathway. Cancer Cell Int 2021;21:320. [PMID: 34174897 DOI: 10.1186/s12935-021-02022-7] [Reference Citation Analysis]
35 Yu L, Wei J, Liu P. Attacking the PI3K/Akt/mTOR signaling pathway for targeted therapeutic treatment in human cancer. Semin Cancer Biol 2021:S1044-579X(21)00188-7. [PMID: 34175443 DOI: 10.1016/j.semcancer.2021.06.019] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
36 Ma YH, Ma WT, Zhou ZK, Huang X, Jiang XR, Du KJ, Sun MZ, Zhang H, Fang H, Zhao Y, Zhu HM, Liu HX, Chen P, Liu YQ. Synthesis of 8-Fluoroneocryptolepine and Evaluation for Cytotoxic Activity against AGS Cancer Cells. J Nat Prod 2022. [PMID: 35191714 DOI: 10.1021/acs.jnatprod.1c01078] [Reference Citation Analysis]
37 Qiao D, Xing J, Duan Y, Wang S, Yao G, Zhang S, Jin J, Lin Z, Chen L, Piao Y. The molecular mechanism of baicalein repressing progression of gastric cancer mediating miR-7/FAK/AKT signaling pathway. Phytomedicine 2022;100:154046. [DOI: 10.1016/j.phymed.2022.154046] [Reference Citation Analysis]
38 Supruniuk K, Czarnomysy R, Muszyńska A, Radziejewska I. Combined Action of Anti-MUC1 Monoclonal Antibody and Pyrazole-Platinum(II) Complexes Reveals Higher Effectiveness towards Apoptotic Response in Comparison with Monotherapy in AGS Gastric Cancer Cells. Pharmaceutics 2021;13:968. [PMID: 34206951 DOI: 10.3390/pharmaceutics13070968] [Reference Citation Analysis]
39 Zhang S, Wang J, Chen T, Wang J, Wang Y, Yu Z, Zhao K, Zheng K, Chen Y, Wang Z, Li B, Wang C, Huang W, Fu Z, Chen J. α-Actinin1 promotes tumorigenesis and epithelial-mesenchymal transition of gastric cancer via the AKT/GSK3β/β-Catenin pathway. Bioengineered 2021;12:5688-704. [PMID: 34546849 DOI: 10.1080/21655979.2021.1967713] [Reference Citation Analysis]
40 Wang X, He R, Geng L, Yuan J, Fan H. Ginsenoside Rg3 Alleviates Cisplatin Resistance of Gastric Cancer Cells Through Inhibiting SOX2 and the PI3K/Akt/mTOR Signaling Axis by Up-Regulating miR-429. Front Genet 2022;13:823182. [DOI: 10.3389/fgene.2022.823182] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
41 Chen Q, Liu Z, Tan Y, Pan S, An W, Xu H. Characterization of RNA modifications in gastric cancer to identify prognosis-relevant gene signatures. Cancer Med 2022. [PMID: 35635121 DOI: 10.1002/cam4.4861] [Reference Citation Analysis]
42 Sun W, Sun F, Meng J, Cao X, Zhao S, Wang C, Li L, Jiang P. Design, semi-synthesis and bioactivity evaluation of novel podophyllotoxin derivatives as potent anti-tumor agents. Bioorganic Chemistry 2022;126:105906. [DOI: 10.1016/j.bioorg.2022.105906] [Reference Citation Analysis]
43 Ghosh S, Cho SJ. Structural Insights from Molecular Modeling of Isoindolin-1-One Derivatives as PI3Kγ Inhibitors against Gastric Carcinoma. Biomedicines 2022;10:813. [DOI: 10.3390/biomedicines10040813] [Reference Citation Analysis]
44 Wang Z, Lv J, Li X, Lin Q. The flavonoid Astragalin shows anti-tumor activity and inhibits PI3K/AKT signaling in gastric cancer. Chem Biol Drug Des 2021. [PMID: 34396710 DOI: 10.1111/cbdd.13933] [Reference Citation Analysis]
45 Li X, Yang D, Ranganathan P. Editorial: Chemo-Resistance in Gastrointestinal Cancers. Front Oncol 2022;12:821212. [DOI: 10.3389/fonc.2022.821212] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
46 Tang W, Zhu S, Liang X, Liu C, Song L. The Crosstalk Between Long Non-Coding RNAs and Various Types of Death in Cancer Cells. Technol Cancer Res Treat 2021;20:15330338211033044. [PMID: 34278852 DOI: 10.1177/15330338211033044] [Reference Citation Analysis]
47 Gao L, Nie X, Gou R, Hu Y, Dong H, Li X, Lin B. Exosomal ANXA2 derived from ovarian cancer cells regulates epithelial-mesenchymal plasticity of human peritoneal mesothelial cells. J Cell Mol Med 2021. [PMID: 34725902 DOI: 10.1111/jcmm.16983] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
48 Hu S, Ge M, Zhang S, Jiang M, Hu K, Gao L. Integrated Network Pharmacology and Experimental Verification to Explore the Molecular Mechanism of Hedysarum Multijugum Maxim-Curcumae Rhizoma Herb Pair for Treating Non-Small Cell Lung Cancer. Front Oncol 2022;12:854596. [PMID: 35433443 DOI: 10.3389/fonc.2022.854596] [Reference Citation Analysis]